1 |
The Added Value of Diagnostic and Theranostic PET Imaging for the Treatment of CNS Tumors |
|
| | Ilanah J. Pruis,Guus A. M. S. van Dongen,Sophie E. M. Veldhuijzen van Zanten | | | International Journal of Molecular Sciences. 2020; 21(3): 1029 | | | [Pubmed] [Google Scholar] [DOI] | | 2 |
Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors |
|
| | Sandip Basu,Rahul V. Parghane,Rahul V. Kamaldeep,Sudipta Chakraborty | | | Seminars in Nuclear Medicine. 2020; | | | [Pubmed] [Google Scholar] [DOI] | | 3 |
Multidisciplinary Management of Neuroendocrine Neoplasia: A Real-World Experience from a Referral Center |
|
| | Ludovica Magi,Federica Mazzuca,Maria Rinzivillo,Giulia Arrivi,Emanuela Pilozzi,Daniela Prosperi,Elsa Iannicelli,Paolo Mercantini,Michele Rossi,Patrizia Pizzichini,Andrea Laghi,Alberto Signore,Paolo Marchetti,Bruno Annibale,Francesco Panzuto | | | Journal of Clinical Medicine. 2019; 8(6): 910 | | | [Pubmed] [Google Scholar] [DOI] | | 4 |
Theragnostic Use of Radiolabelled Dota-Peptides in Meningioma: From Clinical Demand to Future Applications |
|
| | Riccardo Laudicella,Domenico Albano,Salvatore Annunziata,Diletta Calabṛ,Giovanni Argiroffi,Elisabetta Abenavoli,Flavia Linguanti,Domenico Albano,Antonio Vento,Antonio Bruno,Pierpaolo Alongi,Matteo Bauckneht | | | Cancers. 2019; 11(10): 1412 | | | [Pubmed] [Google Scholar] [DOI] | |
|